Tag: AstraZeneca
Pfizer: Pharmaceutical Sector Is Still a Target for Investors
Revenue of American pharmaceutical company Pfizer Inc. in Q2 2021 jumped 92% on the year to $19 billion, exceeding analyst expectations. Earnings per share in...
Will the Delta variant become a growth catalyst for vaccine concept stocks?
The outbreak of the Delta virus variant in many countries around the world once again caused the market to turn its attention to vaccine...
AstraZeneca Vaccine Dynamics and Q121 Revenue Report
AstraZeneca, one of the leaders in the global race to develop a vaccine for COVID-19, is facing a series of controversies, as both its...
Mid-Week Update – November 25
USD nurses losses as risk sentiment gains traction ahead of the Thanksgiving weekend. Equities & Bitcoin at all-time highs, USOil over $45.00 and Gold...
